Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma

This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration. By participating in this study, participants can receive additional scientific guidance on aspirin medication management beyond routine conservative treatment, thereby optimizing individualized therapy.

NCT Number	NCT07240454
Lead Sponsor	Tao Liu Collaborators: Tianjin Medical University General Hospital, Xuanwu Hospital, Beijing
Conditions	Chronic Subdural Hematoma
Enrollment	143 participants
Start Date	2025-10-15
Primary Completion	2027-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2025-11-21